Scholarlink

<p>Identification of molecular alterations in cancer and advances in technology have enhanced the use of molecular alterations for the diagnosis and treatment of cancer in routine clinical practice. Multi-determination platforms are now available in most Spanish hospitals. First developed in 2021, the objective of these clinical practice guidelines is to review the usefulness of molecular platforms and establish usage guidelines to direct their incorporation into clinical practice. Here, we provide updated guidelines, which include the most recent advancements in this area.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

SEOM‑GETTHI clinical guideline for the practical management of molecular platforms (update 2026)

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年7月27日

查看全文
  • Nuria Rodriguez Salas,
  • Juan de la Haba‑Rodriguez,
  • Ferran Ferragut Lloret,
  • Maria Angeles Vaz Salgado,
  • Martín Oré Arce,
  • Ana Cardeña Gutiérrez,
  • Carmen Beato Zambrano,
  • Rosa María Rodríguez Alonso,
  • Rafael López López,
  • Jesús García‑Donas Jiménez

摘要

Identification of molecular alterations in cancer and advances in technology have enhanced the use of molecular alterations for the diagnosis and treatment of cancer in routine clinical practice. Multi-determination platforms are now available in most Spanish hospitals. First developed in 2021, the objective of these clinical practice guidelines is to review the usefulness of molecular platforms and establish usage guidelines to direct their incorporation into clinical practice. Here, we provide updated guidelines, which include the most recent advancements in this area.